Correlation Between Chunghwa Precision and Li Kang

Can any of the company-specific risk be diversified away by investing in both Chunghwa Precision and Li Kang at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Chunghwa Precision and Li Kang into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Chunghwa Precision Test and Li Kang Biomedical, you can compare the effects of market volatilities on Chunghwa Precision and Li Kang and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Chunghwa Precision with a short position of Li Kang. Check out your portfolio center. Please also check ongoing floating volatility patterns of Chunghwa Precision and Li Kang.

Diversification Opportunities for Chunghwa Precision and Li Kang

-0.66

Correlation Coefficient

Chunghwa Precision  Li Kang

Excellent diversification

The 3 months correlation between Chunghwa and 6242 is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Chunghwa Precision Test and Li Kang Biomedical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Li Kang Biomedical and Chunghwa Precision is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Chunghwa Precision Test are associated (or correlated) with Li Kang. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Li Kang Biomedical has no effect on the direction of Chunghwa Precision i.e., Chunghwa Precision and Li Kang go up and down completely randomly.

Pair Corralation between Chunghwa Precision and Li Kang

Assuming the 90 days trading horizon Chunghwa Precision Test is expected to generate 1.39 times more return on investment than Li Kang. However, Chunghwa Precision is 1.39 times more volatile than Li Kang Biomedical. It trades about 0.06 of its potential returns per unit of risk. Li Kang Biomedical is currently generating about 0.01 per unit of risk. If you would invest  46,524  in Chunghwa Precision Test on September 23, 2024 and sell it today you would earn a total of  34,876  from holding Chunghwa Precision Test or generate 74.96% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Chunghwa Precision Test  vs.  Li Kang Biomedical

Chunghwa Precision Test

Risk-Adjusted Performance

17 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Chunghwa Precision Test are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Chunghwa Precision showed solid returns over the last few months and may actually be approaching a breakup point.

Li Kang Biomedical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Li Kang Biomedical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Li Kang is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Chunghwa Precision and Li Kang

The main advantage of trading using opposite Chunghwa Precision and Li Kang positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Chunghwa Precision position performs unexpectedly, Li Kang can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Li Kang will offset losses from the drop in Li Kang's long position.

The idea behind Chunghwa Precision Test and Li Kang Biomedical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.